Building a medtech portfolio isn’t about chasing every unicorn or avoiding every risk. It’s about managing the complexity—stage, geography, sector exposure, partner bandwidth—and optimizing for a portfolio that performs across cycles. https://www.lsieuropesummit.com/news/medtech-portfolio-optimization-why-investors-say-no-and-what-that-really-means